Cancer is a genetic disease.
When actress Angelina Jolie went segment about her impediment double mastectomy, it did not cord to an increased understanding of the genetic risk of core cancer, researchers say. Although it raised awareness of tit cancer, exposure to Jolie's story may have resulted in greater pot-pourri about the link between a family history of breast cancer and increased cancer risk, according to the study, published Dec 19, 2013 in the annual Genetics in Medicine tarika. Earlier this year, Jolie revealed that she had both breasts removed after information that she carried a metamorphosis in a gene called BRCA1 that is linked to teat and ovarian cancers.
Women with mutations in that gene and the BRCA2 gene have a five times higher imperil of titty cancer and a 10 to 30 times higher danger of developing ovarian cancer than those without the mutations. For the study, researchers surveyed more than 2500 Americans. About 75 percent were wise of Jolie's story, the investigators found go here. But fewer than 10 percent of the respondents could correctly rebutter questions about the BRCA gene transmutation that Jolie carries and the conventional woman's gamble of developing breast cancer.
So "Ms Jolie's robustness story was prominently featured throughout the media and was a chance to levy health communicators and educators to teach about the nuanced issues around genetic testing, jeopardy and preventive surgery," study govern author Dina Borzekowski, a research professor in the University of Maryland School of Public Health's unit of behavior and community health, said in a university intelligence release neenda aan urupu sex. However, it "feels identical to it was a missed opportunity to educate the public about a complex but first-class health situation".